pfizer q2 2025 - Search News

News

Pfizer, Q2 and Earnings Call

Yahoo Finance · 1d

Pfizer Q2 Earnings Preview--Should You Buy, Hold, or Sell?

Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around $13.58 billion, reflecting modest 2% growth on last year, and adjusted EPS near $0.

Seeking Alpha · 21h

Pfizer Inc. (PFE) Q2 2025 Earnings Call Transcript

Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ETCompany ParticipantsAamir Malik - Corporate ParticipantAlbert Bourla

Zacks Investment Research on M… · 1d

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

Pfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks Consensus Estimate of 58 cents per share. Earnings rose 30% year over year. Revenues came in at $14.

Pfizer Raises Profit Outlook

Reuters on MSN · 17h

Pfizer Q2 Results: Pharma major's sales jump to $14.65 billion; firm raises profit forecast for 2025 over cost cuts

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised its profit forecast for 2025 over cost cuts.

Bloomberg on MSN · 1d

Pfizer Raises Profit View as Cost Cuts Offset Poor Sales Growth

Pfizer Inc. raised its profit forecast for the year with the drugmaker’s ongoing cost cuts helping to make up for a lack of sales growth.

CNBC on MSN · 1d

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results

The results come as Pfizer and other drugmakers grapple with Trump's calls to lower U.S. drug prices and brace for his planned tariffs on pharmaceuticals.

22h

Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

9h

U.S. Pfizer Records 10 Percent Growth in Q2 Revenue

Pfizer, the U.S.-based pharmaceutical giant, revealed its second-quarter financial results on Tuesday, showcasing a robust 10 ...

1don MSN

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results